Ivy Altomare

1.7k total citations
58 papers, 1.2k citations indexed

About

Ivy Altomare is a scholar working on Economics and Econometrics, Hematology and Oncology. According to data from OpenAlex, Ivy Altomare has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 18 papers in Hematology and 17 papers in Oncology. Recurrent topics in Ivy Altomare's work include Economic and Financial Impacts of Cancer (20 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Platelet Disorders and Treatments (14 papers). Ivy Altomare is often cited by papers focused on Economic and Financial Impacts of Cancer (20 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Platelet Disorders and Treatments (14 papers). Ivy Altomare collaborates with scholars based in United States, United Kingdom and France. Ivy Altomare's co-authors include S. Yousuf Zafar, Jeffrey Peppercorn, Christel Rushing, Fumiko Chino, Deborah Schrag, James A. Tulsky, Peter A. Ubel, Greg Samsa, Amy P. Abernethy and Gregory P. Samsa and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Ivy Altomare

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivy Altomare United States 18 618 295 200 164 151 58 1.2k
Carol M. Richman United States 21 243 0.4× 359 1.2× 217 1.1× 132 0.8× 433 2.9× 55 1.4k
Sidney Scudder United States 20 246 0.4× 603 2.0× 101 0.5× 130 0.8× 397 2.6× 49 1.9k
Jeanna Welborn United States 17 242 0.4× 263 0.9× 395 2.0× 131 0.8× 424 2.8× 35 1.3k
Lucio Gordan United States 14 137 0.2× 625 2.1× 151 0.8× 91 0.6× 68 0.5× 46 1.1k
Jonas Paludo United States 16 148 0.2× 611 2.1× 129 0.6× 77 0.5× 253 1.7× 150 1.2k
Michael Tanaka United States 13 245 0.4× 582 2.0× 88 0.4× 131 0.8× 377 2.5× 21 1.9k
Carol Townsley Canada 15 242 0.4× 674 2.3× 45 0.2× 104 0.6× 281 1.9× 35 1.4k
Jonas A. de Souza United States 18 1.2k 1.9× 717 2.4× 34 0.2× 161 1.0× 273 1.8× 61 2.2k
S. M. Crawford United Kingdom 20 130 0.2× 612 2.1× 73 0.4× 83 0.5× 149 1.0× 56 1.4k
Therese M. Mulvey United States 12 539 0.9× 697 2.4× 24 0.1× 175 1.1× 356 2.4× 45 1.5k

Countries citing papers authored by Ivy Altomare

Since Specialization
Citations

This map shows the geographic impact of Ivy Altomare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivy Altomare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivy Altomare more than expected).

Fields of papers citing papers by Ivy Altomare

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivy Altomare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivy Altomare. The network helps show where Ivy Altomare may publish in the future.

Co-authorship network of co-authors of Ivy Altomare

This figure shows the co-authorship network connecting the top 25 collaborators of Ivy Altomare. A scholar is included among the top collaborators of Ivy Altomare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivy Altomare. Ivy Altomare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfeffer, M. Raphael, et al.. (2025). Utility of automated data transfer for cancer clinical trials and considerations for implementation. PubMed. 7. 100112–100112.
2.
Guadamuz, Jenny S., Xiaoliang Wang, Ivy Altomare, et al.. (2024). Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023. JNCI Cancer Spectrum. 8(5).
3.
4.
Kent, Seamus, Páll Jónsson, Ivy Altomare, et al.. (2023). Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort study. BMJ Open. 13(10). e074559–e074559. 4 indexed citations
5.
Calip, Gregory S., et al.. (2023). Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022. JAMA Network Open. 6(7). e2322515–e2322515. 57 indexed citations
6.
McGrath, Leah J., Carrie M. Nielson, Bradley Saul, et al.. (2021). Lessons Learned Using Real‐World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune Thrombocytopenia. Clinical Pharmacology & Therapeutics. 110(6). 1570–1578. 4 indexed citations
7.
McGrath, Leah J., Robert A. Overman, Anjali Sharma, et al.. (2020). <p>Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States</p>. Clinical Epidemiology. Volume 12. 435–445. 9 indexed citations
8.
Wilson, Lauren E., Melissa A. Greiner, Ivy Altomare, Jason Rotter, & Michaela A. Dinan. (2020). Rapid rise in the cost of targeted cancer therapies for Medicare patients with solid tumors from 2006 to 2015. Journal of Geriatric Oncology. 12(3). 375–380. 8 indexed citations
9.
Grunwald, Michael R., David J. Kuter, Ivy Altomare, et al.. (2019). Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study. Clinical Lymphoma Myeloma & Leukemia. 20(4). 219–225. 20 indexed citations
10.
Li, Shuling, et al.. (2017). Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study. Current Medical Research and Opinion. 34(2). 209–216. 7 indexed citations
11.
12.
Cetin, Karynsa, Ivy Altomare, Sally Wetten, & Jeffrey S. Wasser. (2016). Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US. Clinical Epidemiology. 8. 231–231. 19 indexed citations
13.
Liu, Yingmiao, Mark D. Starr, John C. Brady, et al.. (2015). Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus. Molecular Cancer Therapeutics. 14(4). 1048–1056. 18 indexed citations
14.
Zafar, S. Yousuf, Fumiko Chino, Peter A. Ubel, et al.. (2015). The utility of cost discussions between patients with cancer and oncologists.. PubMed. 21(9). 607–15. 104 indexed citations
15.
Cines, Douglas B., Terry Gernsheimer, Jeffrey S. Wasser, et al.. (2015). Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim. International Journal of Hematology. 102(3). 259–270. 67 indexed citations
16.
Nussbaum, Nathan C. & Ivy Altomare. (2015). The Neoadjuvant Treatment of Rectal Cancer: A Review. Current Oncology Reports. 17(3). 434–434. 13 indexed citations
17.
Mangas, Cristina, Liqiang Xi, Carlos Ferrándiz, et al.. (2008). Molecular Staging of Pathologically Negative Sentinel Lymph Nodes from Melanoma Patients Using Multimarker, Quantitative Real-Time RT-PCR. Annals of Surgical Oncology. 16(1). 177–85. 16 indexed citations
18.
Altomare, Ivy, A Adler, & Louis M. Aledort. (2007). The 5, 10 methylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: a case series and review of the literature. Thrombosis Journal. 5(1). 17–17. 23 indexed citations
19.
Altomare, Ivy, Garrett Desman, & Louis M. Aledort. (2006). Echinocytosis—An unusual manifestation of hemangioma. American Journal of Hematology. 81(7). 532–534. 6 indexed citations
20.
Lapointe, Réjean, Richard E. Royal, Mark E. Reeves, et al.. (2001). Retrovirally Transduced Human Dendritic Cells Can Generate T Cells Recognizing Multiple MHC Class I and Class II Epitopes from the Melanoma Antigen Glycoprotein 100. The Journal of Immunology. 167(8). 4758–4764. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carol M. Richman Breakdown of academic impact, for papers by Sidney Scudder Breakdown of academic impact, for papers by Jeanna Welborn Breakdown of academic impact, for papers by Lucio Gordan Breakdown of academic impact, for papers by Jonas Paludo Breakdown of academic impact, for papers by Michael Tanaka Breakdown of academic impact, for papers by Carol Townsley Breakdown of academic impact, for papers by Jonas A. de Souza Breakdown of academic impact, for papers by S. M. Crawford Breakdown of academic impact, for papers by Therese M. Mulvey
Rankless by CCL
2026